[Antineoplastic activity in mice of 4,4'-(2-methyl-1,4-piperazinodiyl)bis-(4-oxo)-propenyl-1-carboxylic-1 acid diethyl ester].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D009368:Neoplasm Transplantation; D010879:Piperazines / Q000627:therapeutic use*; D010885:Pipobroman; D012510:Sarcoma 180 / Q000188:drug therapy*
D000970:Antineoplastic Agents; D010879:Piperazines; C028424:4,4'-(2-methyl-1,4-piperazinodiyl)bis(4-oxo-1-propene-1-carboxylic acid diethyl ester); D010885:Pipobroman
Działanie przeciwnowotworowe estru dwuetylowego kwasu 4,4'-(2-metylo-1,4-piperazynodiylo)-bis[4-okso]-propeno-1-karbopksylowego-1 u myszy.